Jeffrey Bertolini insider trades: Carlsmed (CARL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | CARL | ↓ Sell | 747 | $15.15 | $11K | Direct | Nov 4, 2026 (1d) |
| Oct 30, 2026 | CARL | ↓ Sell | 243 | $15.80 | $4K | Direct | Nov 2, 2026 (3d) |
| Oct 5, 2026 | CARL | ↓ Sell | 747 | $14.39 | $11K | Direct | Oct 6, 2026 (1d) |
| Sep 30, 2026 | CARL | ↓ Sell | 243 | $13.99 | $3K | Direct | Oct 1, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CARL insiders
Open-market trades in the last 12 months
About Jeffrey Bertolini's insider trades
Jeffrey Bertolini is Chief Operating Officer at Carlsmed (CARL). Since Sep 30, 2026, Jeffrey has reported no open-market purchases and 4 sales worth $29K on SEC Form 4. In the last 12 months: 4 sales ($29K).
Their filings also include option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CARL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.